Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure

PLoS ONE

Volumn 12, Issue 3, 2017, Pages

  Kamo, Takehiro ^a   Akazawa, Hiroshi ^a   Suda, Wataru ^b,c   Saga Kamo, Akiko ^a   Shimizu, Yu ^a   Yagi, Hiroki ^a   Liu, Qing ^a   Nomura, Seitaro ^a   Naito, Atsuhiko T ^a   Takeda, Norifumi ^a   Harada, Mutsuo ^a   Toko, Haruhiro ^a   Kumagai, Hidetoshi ^a   Ikeda, Yuichi ^a   Takimoto, Eiki ^a   Suzuki, Jun Ichi ^a   Honda, Kenya ^c,d   Morita, Hidetoshi ^e   Hattori, Masahira ^b,f   Komuro, Issei ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Institute of Physical and Chemical Research   (Japan)

^e OKAYAMA UNIVERSITY   (Japan)

^f WASEDA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S;

ADULT; AGING; ARTICLE; BACTEROIDETES; CLINICAL ARTICLE; CLOSTRIDIACEAE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DOREA LONGICATENA; DYSBIOSIS; EUBACTERIUM; FAECALIBACTERIUM; FECES ANALYSIS; FECES MICROFLORA; FEMALE; GENE SEQUENCE; HEART FAILURE; HUMAN; INTESTINE FLORA; LACTOBACILLUS; MALE; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; NONHUMAN; POPULATION ABUNDANCE; PRINCIPAL COORDINATE ANALYSIS; PROTEOBACTERIA; RNA GENE; SPECIES COMPOSITION; AGED; CASE CONTROL STUDY; FECES; GENETICS; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; AGING; BACTEROIDETES; CASE-CONTROL STUDIES; DYSBIOSIS; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HEART FAILURE; HUMANS; MALE; MICROBIOTA; MIDDLE AGED; RNA, RIBOSOMAL, 16S;

EID: 85016036470     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0174099     Document Type: Article

References (47)

1. Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014; 157(1):121-41. https://doi.org/10.1016/j.cell.2014.03.011 PMID: 24679531
2. Fischbach MA, Segre JA. Signaling in Host-Associated Microbial Communities. Cell. 2016; 164 (6):1288-300. https://doi.org/10.1016/j.cell.2016.02.037 PMID: 26967294
3. Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nat Rev Genet. 2012; 13(4):260-70. https://doi.org/10.1038/nrg3182 PMID: 22411464
4. Marchesi JR, Adams DH, Fava F, Hermes GD, Hirschfield GM, Hold G, et al. The gut microbiota and host health: a new clinical frontier. Gut. 2016; 65(2):330-9. https://doi.org/10.1136/gutjnl-2015-309990 PMID: 26338727
5. Sandek A, Bauditz J, Swidsinski A, Buhner S, Weber-Eibel J, von Haehling S, et al. Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol. 2007; 50(16):1561-9. https://doi.org/10.1016/j.jacc.2007.07.016 PMID: 17936155
6. Sandek A, Swidsinski A, Schroedl W, Watson A, Valentova M, Herrmann R, et al. Intestinal blood flow in patients with chronic heart failure: a link with bacterial growth, gastrointestinal symptoms, and cachexia. J Am Coll Cardiol. 2014; 64(11):1092-102. https://doi.org/10.1016/j.jacc.2014.06.1179 PMID: 25212642
7. Verbrugge FH, Dupont M, Steels P, Grieten L, Malbrain M, Tang WH, et al. Abdominal contributions to cardiorenal dysfunction in congestive heart failure. J Am Coll Cardiol. 2013; 62(6):485-95. https://doi.org/10.1016/j.jacc.2013.04.070 PMID: 23747781
8. Rogler G, Rosano G. The heart and the gut. Eur Heart J. 2014; 35(7):426-30. https://doi.org/10.1093/eurheartj/eht271 PMID: 23864132
9. Nagatomo Y, Tang WH. Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis. J Card Fail. 2015; 21(12):973-80. https://doi.org/10.1016/j.cardfail.2015.09.017 PMID: 26435097
10. Sundaram V, Fang JC. Gastrointestinal and Liver Issues in Heart Failure. Circulation. 2016; 133 (17):1696-703. https://doi.org/10.1161/CIRCULATIONAHA.115.020894 PMID: 27143152
11. Lekawanvijit S, Kompa AR, Wang BH, Kelly DJ, Krum H. Cardiorenal syndrome: the emerging role of protein-bound uremic toxins. Circ Res. 2012; 111(11):1470-83. https://doi.org/10.1161/CIRCRESAHA. 112.278457 PMID: 23139286
12. Tang WH, Wang Z, Fan Y, Levison B, Hazen JE, Donahue LM, et al. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis. J Am Coll Cardiol. 2014; 64(18):1908-14. https://doi.org/10.1016/j.jacc.2014.02. 617 PMID: 25444145
13. Organ CL, Otsuka H, Bhushan S, Wang Z, Bradley J, Trivedi R, et al. Choline Diet and Its Gut Microbe-Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload-Induced Heart Failure. Circ Heart Fail. 2016; 9(1):e002314. https://doi.org/10.1161/CIRCHEARTFAILURE.115.002314 PMID: 26699388
14. Lam V, Su J, Koprowski S, Hsu A, Tweddell JS, Rafiee P, et al. Intestinal microbiota determine severity of myocardial infarction in rats. Faseb J. 2012; 26(4):1727-35. Epub 2012/01/17. https://doi.org/10.1096/fj.11-197921 PMID: 22247331
15. Gan XT, Ettinger G, Huang CX, Burton JP, Haist JV, Rajapurohitam V, et al. Probiotic administration attenuates myocardial hypertrophy and heart failure after myocardial infarction in the rat. Circ Heart Fail. 2014; 7(3):491-9. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000978 PMID: 24625365
16. Morita H, Kuwahara T, Oshima K, Sasamoto H, Itoh K, Hattori M, et al. An improved DNA isolation method for metagenomic analysis of the microbial flora of the human intestine. Microbes Environ. 2007; 22(3):214-22.
17. Kim SW, Suda W, Kim S, Oshima K, Fukuda S, Ohno H, et al. Robustness of gut microbiota of healthy adults in response to probiotic intervention revealed by high-throughput pyrosequencing. DNA Res. 2013; 20(3):241-53. https://doi.org/10.1093/dnares/dst006 PMID: 23571675
18. Lozupone C, Lladser ME, Knights D, Stombaugh J, Knight R. UniFrac: an effective distance metric for microbial community comparison. ISME J. 2011; 5(2):169-72. https://doi.org/10.1038/ismej.2010.133 PMID: 20827291
19. Lozupone CA, Hamady M, Kelley ST, Knight R. Quantitative and qualitative beta diversity measures lead to different insights into factors that structure microbial communities. Appl Environ Microbiol. 2007; 73(5):1576-85. https://doi.org/10.1128/AEM.01996-06 PMID: 17220268
20. Lazzarini V, Mentz RJ, Fiuzat M, Metra M, O'Connor CM. Heart failure in elderly patients: distinctive features and unresolved issues. Eur J Heart Fail. 2013; 15(7):717-23. https://doi.org/10.1093/eurjhf/hft028 PMID: 23429975
21. Mukherjee S, Hooper LV. Antimicrobial defense of the intestine. Immunity. 2015; 42(1):28-39. https://doi.org/10.1016/j.immuni.2014.12.028 PMID: 25607457
22. Pasini E, Aquilani R, Testa C, Baiardi P, Angioletti S, Boschi F, et al. Pathogenic Gut Flora in Patients With Chronic Heart Failure. JACC Heart Fail. 2016; 4(3):220-7. https://doi.org/10.1016/j.jchf.2015.10.009 PMID: 26682791
23. Wright EK, Kamm MA, Teo SM, Inouye M, Wagner J, Kirkwood CD. Recent advances in characterizing the gastrointestinal microbiome in Crohn's disease: a systematic review. Inflamm Bowel Dis. 2015; 21 (6):1219-28. https://doi.org/10.1097/MIB.0000000000000382 PMID: 25844959
24. Karlsson F, Tremaroli V, Nielsen J, Backhed F. Assessing the human gut microbiota in metabolic diseases. Diabetes. 2013; 62(10):3341-9. https://doi.org/10.2337/db13-0844 PMID: 24065795
25. Yang T, Santisteban MM, Rodriguez V, Li E, Ahmari N, Carvajal JM, et al. Gut dysbiosis is linked to hypertension. Hypertension. 2015; 65(6):1331-40. https://doi.org/10.1161/HYPERTENSIONAHA.115. 05315 PMID: 25870193
26. Arora T, Backhed F. The gut microbiota and metabolic disease: current understanding and future perspectives. J Intern Med. 2016; 280(4):339-49. https://doi.org/10.1111/joim.12508 PMID: 27071815
27. Santisteban MM, Kim S, Pepine CJ, Raizada MK. Brain-Gut-Bone Marrow Axis: Implications for Hypertension and Related Therapeutics. Circ Res. 2016; 118(8):1327-36. https://doi.org/10.1161/CIRCRESAHA.116.307709 PMID: 27081113
28. Collins MD, Lawson PA, Willems A, Cordoba JJ, Fernandez-Garayzabal J, Garcia P, et al. The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations. Int J Syst Bacteriol. 1994; 44(4):812-26. https://doi.org/10.1099/00207713-44-4-812 PMID: 7981107
29. Taras D, Simmering R, Collins MD, Lawson PA, Blaut M. Reclassification of Eubacterium formicigenerans Holdeman and Moore 1974 as Dorea formicigenerans gen. nov., comb. nov., and description of Dorea longicatena sp. nov., isolated from human faeces. Int J Syst Evol Microbiol. 2002; 52(Pt 2):423-8. https://doi.org/10.1099/00207713-52-2-423 PMID: 11931151
30. Louis P, Flint HJ. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett. 2009; 294(1):1-8. https://doi.org/10.1111/j.1574-6968. 2009.01514.x PMID: 19222573
31. Leonel AJ, Alvarez-Leite JI. Butyrate: implications for intestinal function. Curr Opin Clin Nutr Metab Care. 2012; 15(5):474-9. https://doi.org/10.1097/MCO.0b013e32835665fa PMID: 22797568
32. Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013; 504(7480):446-50. Epub 2013/11/15. https://doi.org/10.1038/nature12721 PMID: 24226770
33. Lopez CA, Kingsbury DD, Velazquez EM, Baumler AJ. Collateral damage: microbiota-derived metabolites and immune function in the antibiotic era. Cell Host Microbe. 2014; 16(2):156-63. https://doi.org/10.1016/j.chom.2014.07.009 PMID: 25121745
34. Duncan SH, Holtrop G, Lobley GE, Calder AG, Stewart CS, Flint HJ. Contribution of acetate to butyrate formation by human faecal bacteria. Br J Nutr. 2004; 91(6):915-23. https://doi.org/10.1079/BJN20041150 PMID: 15182395
35. Perry RJ, Peng L, Barry NA, Cline GW, Zhang D, Cardone RL, et al. Acetate mediates a microbiomebrain-beta-cell axis to promote metabolic syndrome. Nature. 2016; 534(7606):213-7. https://doi.org/10.1038/nature18309 PMID: 27279214
36. Joice R, Yasuda K, Shafquat A, Morgan XC, Huttenhower C. Determining microbial products and identifying molecular targets in the human microbiome. Cell Metab. 2014; 20(5):731-41. https://doi.org/10.1016/j.cmet.2014.10.003 PMID: 25440055
37. Romano KA, Vivas EI, Amador-Noguez D, Rey FE. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. MBio. 2015; 6(2):e02481. https://doi.org/10.1128/mBio.02481-14 PMID: 25784704
38. Wang Z, Roberts AB, Buffa JA, Levison BS, Zhu W, Org E, et al. Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis. Cell. 2015; 163(7):1585-95. https://doi.org/10.1016/j.cell.2015.11.055 PMID: 26687352
39. Falony G, Joossens M, Vieira-Silva S, Wang J, Darzi Y, Faust K, et al. Population-level analysis of gut microbiome variation. Science. 2016; 352(6285):560-4. https://doi.org/10.1126/science.aad3503 PMID: 27126039
40. Zhernakova A, Kurilshikov A, Bonder MJ, Tigchelaar EF, Schirmer M, Vatanen T, et al. Populationbased metagenomics analysis reveals markers for gut microbiome composition and diversity. Science. 2016; 352(6285):565-9. https://doi.org/10.1126/science.aad3369 PMID: 27126040
41. Imhann F, Bonder MJ, Vich Vila A, Fu J, Mujagic Z, Vork L, et al. Proton pump inhibitors affect the gut microbiome. Gut. 2016; 65(5):740-8. https://doi.org/10.1136/gutjnl-2015-310376 PMID: 26657899
42. Jackson MA, Goodrich JK, Maxan ME, Freedberg DE, Abrams JA, Poole AC, et al. Proton pump inhibitors alter the composition of the gut microbiota. Gut. 2016; 65(5):749-56. https://doi.org/10.1136/gutjnl-2015-310861 PMID: 26719299
43. Claesson MJ, Cusack S, O'Sullivan O, Greene-Diniz R, de Weerd H, Flannery E, et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proceedings of the National Academy of Sciences of the United States of America. 2011; 108 Suppl 1:4586-91.
44. Claesson MJ, Jeffery IB, Conde S, Power SE, O'Connor EM, Cusack S, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature. 2012; 488(7410):178-84. https://doi.org/10.1038/nature11319 PMID: 22797518
45. Loffredo FS, Nikolova AP, Pancoast JR, Lee RT. Heart failure with preserved ejection fraction: molecular pathways of the aging myocardium. Circ Res. 2014; 115(1):97-107. https://doi.org/10.1161/CIRCRESAHA.115.302929 PMID: 24951760
46. O'Toole PW, Jeffery IB. Gut microbiota and aging. Science. 2015; 350(6265):1214-5. https://doi.org/10.1126/science.aac8469 PMID: 26785481
47. Zmora N, Zeevi D, Korem T, Segal E, Elinav E. Taking it Personally: Personalized Utilization of the Human Microbiome in Health and Disease. Cell Host Microbe. 2016; 19(1):12-20. https://doi.org/10.1016/j.chom.2015.12.016 PMID: 26764593